Let's hope NF can get something right (is that too much to ask) and come out with the scoping studies and revised JORC by the end of March. Track record isn't good however IMO!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025